POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis
Clinical trial NCT05932654 · COMPLETED
Trial details
- NCT number
- NCT05932654
- Sponsor
- Biosion, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-31
- Primary completion
- 2024-09-18
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.